EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET

YILDIZHAN, İncilay KALAY; KUNDAKCI, NİHAL; SÜRGÜN, Ece

doi:10.31086/tjgeri.2020.156

EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET

İncilay KALAY YILDIZHAN, (Ankara Üniversitesi, Tıp Fakültesi, Dermatoloji Anabilim Dalı, Ankara, Türkiye)

Ece SÜRGÜN, (Ankara Üniversitesi, Tıp Fakültesi, Dermatoloji Anabilim Dalı, Ankara, Türkiye)

Nihal KUNDAKÇI (Ankara Üniversitesi, Tıp Fakültesi, Dermatoloji Anabilim Dalı, Ankara, Türkiye)

Türk Geriatri Dergisi

2 0

Yıl: 2020 Cilt: 23 Sayı: 2 Sayfa Aralığı: 216 - 223 Metin Dili: İngilizce DOI: 10.31086/tjgeri.2020.156 İndeks Tarihi: 22-10-2020

EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET

Öz:

Introduction: There is limited data regarding epidemiological and clinical characteristics of psoriasis in the elderly population. We sought to demonstrate epidemiological and clinical features, treatments, and comorbidities in elderly patients with psoriasis. Additionally, we evaluated whether the age at disease onset had an impact on disease characteristics.Materials and Method: We performed a retrospective review of 508 psoriasis cases and evaluated 89 patients, older than 65-years-old, with psoriasis. Patients were divided into two groups according to the age at disease onset: early-onset psoriasis (before age 40) and late-onset psoriasis (after age 40). All data were compared for the two groups.Results: Elderly patients with psoriasis comprised 17.6% of all patients. The median age was 70-years-old, with a male to female ratio of 1.4. Past family history was known for 25% of patients. The primary subtype was plaque-type psoriasis and 78.7% of patients had moderate-severe psoriasis. The two common comorbidities were hypertension (57.3%) and diabetes mellitus (33.7%). In total, 32.5% had early-onset psoriasis and 67.5% had late-onset psoriasis. Patients with early-onset psoriasis had a significantly higher prevalence in their family history (p=0.020). There was no significant difference between clinical subtypes, disease severity, nail and joint involvement, or treatment modalities, according to the age at disease onset. Nevertheless, we found a statistically significant correlation between late-onset psoriasis and hypertension (p=0.014).Conclusion: This study underlined epidemiological and clinical features of psoriasis in the elderly. Excluding hypertension, the age at disease onset did not show an impact on disease characteristics or comorbidities.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Stuart P, Malick F, Nair RP, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res. 2002;294(5):207-13. (PMID:12115023).
2. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology. 1985;13(3):450-6. (PMID:4056119).
3. Balato N, Patruno C, Napolitano M, et al. Managing moderate-to-severe psoriasis in the elderly. Drugs Aging. 2014;31(4):233-8. (PMID:24554398).
4. Phan C, Sigal ML, Esteve E, et al. Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis. J Eur Acad Dermatol Venereol. 2016;30(1):78-82. (PMID:25389080).
5. Yap KB, Siew MG, Goh CL. Pattern of skin diseases in the elderly seen at the National Skin Centre (Singapore) 1990. Singapore Med J. 1994;35(2):147- 50. (PMID:7939809).
6. Gligora M, Arzensek J, Rems D, Troskot N, Banjanin M. Psoriasis in the third age. Acta dermatovenereologica Supplementum. 1989;146:168-70. (PMID:2692371).
7. Liao YH, Chen KH, Tseng MP, Sun CC. Pattern of skin diseases in a geriatric patient group in Taiwan: a 7-year survey from the outpatient clinic of a university medical center. Dermatology. 2001;203(4):308-13. (PMID:11752818).
8. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J. A population genetic study of psoriasis. The British journal of dermatology. 1994;131(1):32-9. (PMID:8043420).
9. Oh EH, Ro YS, Kim JE. Epidemiology and cardiovascular comorbidities in patients with psoriasis: A Korean nationwide population-based cohort study. The Journal of dermatology. 2017;44(6):621-9. (PMID:28191654).
10. Napolitano M, Balato N, Ayala F, et al. Psoriasis in elderly and non-elderly population: clinical and molecular features. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2016;151(6):587-95. (PMID:26199090).
11. Yosipovitch G, Tang MB. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging. 2002;19(11):847-63. (PMID:12428994).
12. Morici N, Ferri LA, Alicandro G, et al. Psoriasis and the risk of acute coronary syndrome in the elderly. Int J Cardiol. 2018;273:44-6. (PMID:30064923).
13. Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderlyonset psoriasis a distinct subtype? Int J Dermatol. 2012;51(1):53-8. (PMID:22182378).
14. Korman NJ. Management of psoriasis as a systemic disease: What is the evidence? The British journal of dermatology. 2019. (PMID:31225638).
15. Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol. 2010;130(5):1213-26. (PMID:19812592).
16. Balato A, Di Costanzo L, Patruno C, et al. Psoriasis or “psoriases”? Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2013;148(6):649-50. (PMID:24442045).
17. Ejaz A, Raza N, Iftikhar N, Iftikhar A, Farooq M. Presentation of early onset psoriasis in comparison with late onset psoriasis: a clinical study from Pakistan. Indian journal of dermatology, venereology and leprology. 2009;75(1):36-40. (PMID:19172029).
18. Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. Journal of the American Academy of Dermatology. 2002;46(6):867- 73. (PMID:12063483).
19. Fan X, Yang S, Sun LD, et al. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta dermato-venereologica. 2007;87(4):335-40. (PMID:17598037).
20. Chularojanamontri L, Kulthanan K, Suthipinittharm P, et al. Clinical differences between early- and late-onset psoriasis in Thai patients. Int J Dermatol. 2015;54(3):290-4. (PMID:25069524).
21. Guinot C, Latreille J, Perrussel M, et al. Psoriasis: characterization of six different clinical phenotypes. Experimental dermatology. 2009;18(8):712-9. (PMID:19366373).
22. Golden JB, Wang Y, Fritz Y, et al. Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models. J Transl Med. 2015;13:382. (PMID:26675482).
23. Elkamshoushi AM, Omar SS, El Abd AM, et al. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-alpha, age of onset, and body fat. Int J Dermatol. 2019;58(4):456-64. (PMID:30471086).
24. Hajiebrahimi M, Linder M, Hagg D, et al. Young patients with risk factors prevalent in the elderly - differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers. Clinical epidemiology. 2018;10:705-15. (PMID:29950900).
25. Queiro R, Lorenzo A, Tejon P, Pardo E, Coto P. Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease. Clinical rheumatology. 2019;38(8):2063-68. (PMID:30924009).

APA	YILDIZHAN İ, SÜRGÜN E, KUNDAKCI N (2020). EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. , 216 - 223. 10.31086/tjgeri.2020.156
Chicago	YILDIZHAN İncilay KALAY,SÜRGÜN Ece,KUNDAKCI NİHAL EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. (2020): 216 - 223. 10.31086/tjgeri.2020.156
MLA	YILDIZHAN İncilay KALAY,SÜRGÜN Ece,KUNDAKCI NİHAL EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. , 2020, ss.216 - 223. 10.31086/tjgeri.2020.156
AMA	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. . 2020; 216 - 223. 10.31086/tjgeri.2020.156
Vancouver	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. . 2020; 216 - 223. 10.31086/tjgeri.2020.156
IEEE	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N "EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET." , ss.216 - 223, 2020. 10.31086/tjgeri.2020.156
ISNAD	YILDIZHAN, İncilay KALAY vd. "EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET". (2020), 216-223. https://doi.org/10.31086/tjgeri.2020.156

APA	YILDIZHAN İ, SÜRGÜN E, KUNDAKCI N (2020). EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. Türk Geriatri Dergisi, 23(2), 216 - 223. 10.31086/tjgeri.2020.156
Chicago	YILDIZHAN İncilay KALAY,SÜRGÜN Ece,KUNDAKCI NİHAL EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. Türk Geriatri Dergisi 23, no.2 (2020): 216 - 223. 10.31086/tjgeri.2020.156
MLA	YILDIZHAN İncilay KALAY,SÜRGÜN Ece,KUNDAKCI NİHAL EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. Türk Geriatri Dergisi, vol.23, no.2, 2020, ss.216 - 223. 10.31086/tjgeri.2020.156
AMA	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. Türk Geriatri Dergisi. 2020; 23(2): 216 - 223. 10.31086/tjgeri.2020.156
Vancouver	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET. Türk Geriatri Dergisi. 2020; 23(2): 216 - 223. 10.31086/tjgeri.2020.156
IEEE	YILDIZHAN İ,SÜRGÜN E,KUNDAKCI N "EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET." Türk Geriatri Dergisi, 23, ss.216 - 223, 2020. 10.31086/tjgeri.2020.156
ISNAD	YILDIZHAN, İncilay KALAY vd. "EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS, TREATMENTS, AND COMORBIDITIES IN ELDERLY PATIENTS WITH PSORIASIS AND THE EVALUATION OF PATIENTS ACCORDING TO THE AGE OF ONSET". Türk Geriatri Dergisi 23/2 (2020), 216-223. https://doi.org/10.31086/tjgeri.2020.156